Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioMarin Pharmaceutical Inc. - Common Stock (NQ:BMRN)

65.02 +0.39 (+0.60%)
Streaming Delayed Price Updated: 2:23 PM EDT, Sep 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 667,936
Open 63.83
Bid (Size) 64.99 (100)
Ask (Size) 65.05 (100)
Prev. Close 64.63
Today's Range 63.64 - 65.31
52wk Range 49.26 - 70.98
Shares Outstanding 183,352,255
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Reasons to Avoid BMRN and 1 Stock to Buy Instead
BioMarin Pharmaceutical trades at $66.53 and has moved in lockstep with the market. Its shares have returned 9.3% over the last six months while the S&P 500 ... 
Via StockStory
Topics Stocks
News headline image
3 Value Stocks We Think Twice About
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory

Performance

YTD
+9.4%
+9.4%
1 Month
-5.6%
-5.6%
3 Month
+12.3%
+12.3%
6 Month
+6.8%
+6.8%
1 Year
+15.3%
+15.3%

More News

Read More
BioMarin (NASDAQ:BMRN) Stands Out as an Undervalued Stock with Solid Fundamentals ↗
Via Chartmill
News headline image
Therapeutics Stocks Q2 Results: Benchmarking BioMarin Pharmaceutical (NASDAQ:BMRN)
Via StockStory
Topics Artificial Intelligence
News headline image
Why BioMarin Pharmaceutical (BMRN) Stock Is Up Today
Via StockStory
BioMarin Pharmaceutical (NASDAQ:BMRN): A Value Stock with Strong Fundamentals ↗
Via Chartmill
BioMarin Pharmaceutical (NASDAQ:BMRN) Presents a High-Quality Breakout Setup with Strong Technical Ratings ↗
Via Chartmill
BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Shows Strong Value Potential with a 7/10 Overall Rating ↗
Via Chartmill
News headline image
3 Cash-Producing Stocks We Find Risky
Via StockStory
News headline image
BioMarin Targets Faster Deleveraging as Amicus Deal Expands Rare-Disease Growth ↗
Via MarketBeat
News headline image
BioMarin Pharmaceutical (BMRN) Stock Is Up, What You Need To Know
Via StockStory
News headline image
BioMarin Pharmaceutical Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): A Decent Value Play with Strong Fundamentals ↗
Via Chartmill
News headline image
BioMarin Pharmaceutical (NASDAQ:BMRN) Delivers Impressive Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations
Via StockStory
News headline image
BioMarin Pharmaceutical (BMRN) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
News headline image
1 Profitable Stock with Impressive Fundamentals and 2 We Turn Down
Via StockStory
News headline image
2 Reasons to Avoid BMRN and 1 Stock to Buy Instead
Via StockStory
Topics Artificial Intelligence
News headline image
1 of Wall Street’s Favorite Stocks with Competitive Advantages and 2 We Avoid
Via StockStory
News headline image
2 Cash-Heavy Stocks with Exciting Potential and 1 We Ignore
Via StockStory
News headline image
2 Healthcare Stocks for Long-Term Investors and 1 We Brush Off
Via StockStory
News headline image
Therapeutics Stocks Q1 Teardown: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest
Via StockStory
Topics Artificial Intelligence
News headline image
2 Profitable Stocks Worth Your Attention and 1 We Find Risky
Via StockStory
News headline image
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why BioMarin Pharmaceutical (BMRN) Stock Is Trading Up Today
Via StockStory
News headline image
1 Small-Cap Stock with Solid Fundamentals and 2 We Find Risky
Via StockStory

Frequently Asked Questions

Is BioMarin Pharmaceutical Inc. - Common Stock publicly traded?
Yes, BioMarin Pharmaceutical Inc. - Common Stock is publicly traded.
What exchange does BioMarin Pharmaceutical Inc. - Common Stock trade on?
BioMarin Pharmaceutical Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock?
The ticker symbol for BioMarin Pharmaceutical Inc. - Common Stock is BMRN on the Nasdaq Stock Market
What is the current price of BioMarin Pharmaceutical Inc. - Common Stock?
The current price of BioMarin Pharmaceutical Inc. - Common Stock is 65.02
When was BioMarin Pharmaceutical Inc. - Common Stock last traded?
The last trade of BioMarin Pharmaceutical Inc. - Common Stock was at 09/09/26 02:23 PM ET
What is the market capitalization of BioMarin Pharmaceutical Inc. - Common Stock?
The market capitalization of BioMarin Pharmaceutical Inc. - Common Stock is 11.92B
How many shares of BioMarin Pharmaceutical Inc. - Common Stock are outstanding?
BioMarin Pharmaceutical Inc. - Common Stock has 12B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.